Free tool
Cell therapy stocks
We cover 4 companies grouped under the Cell therapy theme. The median market value in the group is $734.95M. Across the group, the median move over the past trading day is +3.20%. Price change over the past year runs from −9.1% to +486.9% across the middle 80 percent of the group, with a median of +146.8%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
4 of 86 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| BLFS | BioLife Solutions, Inc. | $37.22 | +24.94% | +55.80% | +45.11% |
| IMMX | Immix Biopharma, Inc. | $14.47 | +66.51% | +166.48% | +589.05% |
| 0JDK.L | Iovance Biotherapeutics, Inc. | $8.36 | +1.91% | +222.92% | +248.46% |
| 219A.T | HEARTSEED INC | 2,365.00 JPY | +36.94% | +31.02% | −32.33% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.